• Best Practices New Normal
  • Digital Dentistry
  • Data Security
  • Implants
  • Catapult Education
  • COVID-19
  • Digital Imaging
  • Laser Dentistry
  • Restorative Dentistry
  • Cosmetic Dentistry
  • Periodontics
  • Oral Care
  • Evaluating Dental Materials
  • Cement and Adhesives
  • Equipment & Supplies
  • Ergonomics
  • Products
  • Dentures
  • Infection Control
  • Orthodontics
  • Technology
  • Techniques
  • Materials
  • Emerging Research
  • Pediatric Dentistry
  • Endodontics
  • Oral-Systemic Health

BioMin Restore Plus Toothpaste for sensitivity receives FDA approval

Article

Dr. Collins has announced FDA approval of its BioMin Restore Plus toothpaste for hypersensitivity.

Dr. Collins has announced its new BioMin Restore Plus Toothpaste has received FDA 510K approval for sensitivity relief. Reportedly the first fluoride-containing bioactive glass toothpaste to be approved for sale in the US, BioMin Restore Plus is available by prescription only.

The toothpaste is designed to control the release of calcium, phosphate, and fluoride ions for hours after brushing, which is said to develop acid-resistant fluorapatite on the tooth surface and inside exposed dentin tubules. BioMin Restore Plus is based on BioMin® F, a patented bioactive glass complex developed at Queen Mary University of London.

After brushing, BioMin Restore Plus’ active ingredient adheres to the tooth’s surface, where microscopic particles slowly dissolve over an 8 to 12 hour period. During this dissolving period, the particles are constantly releasing calcium, phosphate, and fluoride ions. These combine to deposit fluorapatite, which is similar to natural tooth enamel but is said to be more acid-resistant. It’s also designed to fill any exposed dentin tubules, plugging them to prevent the fluid flow which can cause hypersensitivity.

“There are many causes of dentine hypersensitivity which means that previously no single toothpaste worked for everyone,” said Dr. David Gillam, BioMin’s clinical consultant. “One of the advantages of BioMin is that it provides a constant supply of low levels of fluoride, calcium, and phosphate in the biofilm/saliva/dental interface, which allows fluorapatite to be deposited gradually.”

“We are delighted that the FDA has given us the approval to provide BioMin Restore Plus toothpaste to the American public via the dental profession,” said Dr. Colin Suzman, founder of Dr. Collins, Inc. “It is a real achievement for a start-up organization to achieve this result. We believe this ground-breaking technology will bring considerable benefit to many sufferers of dentine hypersensitivity. We are now proceeding to full production and hope to have the product available by end of Q1 2021.”

For more information, visit biomintoothpaste.com or drcollins.com.


Related Videos
2024 Dental Products Report Spring Selection Bracket Reveal Video
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
Product Bites – March 8, 2024 Part 2
Product Bites – March 8, 2024 Part 1
Greater New York Dental Meeting 2023 – Interview with Emily Boge, EdD, RDH, CDA, FAADH, FADHA - Paradise Dental Technologies
Greater New York Dental Meeting 2023 – Interview with Suzanne Cano from LunaLite Dental
 Product Bites – August 11, 2023
AHDA23 Annual Conference in 4 Minutes
© 2024 MJH Life Sciences

All rights reserved.